Rubra Medicaments Limited announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced total revenue was INR 0.875 million compared to INR 1.4 million a year ago. Net income was INR 0.061 million compared to INR 0.078 million a year ago. Basic earnings per share from continuing operations was INR 0.01 compared to INR 0.01 a year ago. For the half year, total revenue was INR 0.875 million compared to INR 2.326 million a year ago. Net income was INR 0.001 million compared to INR 0.193 million a year ago. Basic eps - continuing operations was INR 0 compared to INR 0.04 a year ago.